Last year, I attended the Bio International Convention (Bio 2014). Easily one of the most talked about topics was how to integrate data management across drug development phases. One thing I keep going back to is how important it is to integrate automation early, particularly level 3 automation (even in clinical and development stages), in the era of faster tech transfer and single-use equipment and flexible facilities.
Advances in level 3 automation in combination with single-use equipment and flexible facility provide unique opportunities in reducing time to market and managing risks in drug development business. That’s something as an industry we’ve made progress on, but we’re still figuring out. One of the challenges is how to develop the industrial standardards that will speed up this process and allow the drug manufacturers to achieve the goal of reducing time to market.
We’re going to explore this further at the 2015 Life Sciences Symposium hosted by Emerson on April 14-16. I’d highly recommend if you’re interested in discussing data integration, process intelligence and analytics, flexible facilities, and single-use technologies with 100 industry experts from leading pharma and biotech companies that you consider attending the Symposium.